Zura Bio (ZURA)
NASDAQ:ZURA
Total Valuation
Zura Bio has a market cap or net worth of $533.23M. The enterprise value is $283.33M.
Market Cap$533.23M
Enterprise Value$283.33M
Share Statistics
Zura Bio has 94,880,710 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding94,880,710
Owned by Insiders12.82%
Owned by Institutions35.62%
Financial Efficiency
Zura Bio’s return on equity (ROE) is -0.98 and return on invested capital (ROIC) is -74.11%.
Return on Equity (ROE)-0.98
Return on Assets (ROA)-0.87
Return on Invested Capital (ROIC)-74.11%
Return on Capital Employed (ROCE)-0.74
Revenue Per Employee0.00
Profits Per Employee-2.29M
Employee Count30
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Zura Bio is ―. Zura Bio’s PEG ratio is -0.06.
PE Ratio―
PS Ratio0.00
PB Ratio4.86
Price to Fair Value4.86
Price to FCF-7.60
Price to Operating Cash Flow-8.77
PEG Ratio-0.06
Income Statement
In the last 12 months, Zura Bio had revenue of 0.00 and earned -99.35M in profits. Earnings per share was -1.06.
Revenue0.00
Gross Profit-49.00K
Operating Income-75.25M
Pretax Income-68.65M
Net Income-99.35M
EBITDA-75.25M
Earnings Per Share (EPS)-1.06
Cash Flow
In the last 12 months, operating cash flow was -64.81M and capital expenditures -113.00K, giving a free cash flow of -64.93M billion.
Operating Cash Flow-64.81M
Free Cash Flow-64.93M
Free Cash Flow per Share-0.68
Dividends & Yields
Zura Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.57
52-Week Price Change314.76%
50-Day Moving Average6.18
200-Day Moving Average3.65
Relative Strength Index (RSI)40.99
Average Volume (3m)519.62K
Important Dates
Zura Bio upcoming earnings date is May 7, 2026, Before Open (Confirmed).
Last Earnings DateMar 19, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
Zura Bio as a current ratio of 9.05, with Debt / Equity ratio of 0.00%
Current Ratio9.05
Quick Ratio9.05
Debt to Market Cap0.00
Net Debt to EBITDA1.45
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Zura Bio has paid 30.70M in taxes.
Income Tax30.70M
Effective Tax Rate0.00
Enterprise Valuation
Zura Bio EV to EBITDA ratio is -5.10, with an EV/FCF ratio of -5.91.
EV to Sales0.00
EV to EBITDA-5.10
EV to Free Cash Flow-5.91
EV to Operating Cash Flow-5.92
Balance Sheet
Zura Bio has $109.41M in cash and marketable securities with $0.00 in debt, giving a net cash position of $109.41M billion.
Cash & Marketable Securities$109.41M
Total Debt$0.00
Net Cash$109.41M
Net Cash Per Share$1.15
Tangible Book Value Per Share$1.08
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Zura Bio is $17.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$17.75
Price Target Upside215.84% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast-19.69%